Copy Link Print Information

Dilpacimab

(Synonyms: ABT165; PR1283233)
Revisión del cliente

Based on 1 Customer Validation

Dilpacimab (ABT165) is a bispecific variable domain immunoglobulin. Dilpacimab binds to and inhibits DLL4 and VEGF and acts as a tumor growth inhibitor. Dilpacimab can be used in research related to metastatic colorectal cancer and advanced solid tumors.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 96.88%
  • No. CAS: 1791420-09-1
  • Peso molecular:199.12 kDa
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Dilpacimab
  • Experimental Validation Results for Dilpacimab
  • Experimental Validation Results for Dilpacimab
  • Dilpacimab Chemical Structure
    Dilpacimab Chemical Structure
No. CAS: 1791420-09-1
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Dilpacimab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Ver todos los productos específicos de isoformas VEGFR

More
Keywords
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    [VH-VH'-H-Gamma1_VL-VL'-C-kappa]-dimer

  • 1/16

    Immobilized Delta-like protein 4/DLL4 Protein, Human can bind Dilpacimab. The EC50 for this effect is 5.82 ng/mL.

  • 1/16

    Flow cytometric analysis of 1X106 HeLa cells with Dilpacimab (HY-P99852, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. AF 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control.

  • Dilpacimab Chemical Structure
    1/16
  • Dilpacimab
  • Immobilized Delta-like protein 4/DLL4 Protein, Human can bind Dilpacimab. The EC50 for this effect is 5.82 ng/mL.
  • Flow cytometric analysis of 1X106 HeLa cells with Dilpacimab (HY-P99852, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. AF 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control.
  • [VH-VH'-H-Gamma1_VL-VL'-C-kappa]-dimer